907 related articles for article (PubMed ID: 18310290)
1. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin-Immunoreactive Pancreaticoduodenal Neuroendocrine Neoplasms: Twenty-Three Cases Evaluated according to the WHO 2010 Classification.
Luna IE; Monrad N; Binderup T; Boisen Thoegersen C; Hilsted L; Jensen C; Federspiel B; Knigge U
Neuroendocrinology; 2016; 103(5):567-77. PubMed ID: 26505735
[TBL] [Abstract][Full Text] [Related]
3. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
4. Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance.
Anlauf M; Perren A; Klöppel G
Pathobiology; 2007; 74(5):279-84. PubMed ID: 17890894
[TBL] [Abstract][Full Text] [Related]
5. Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas.
Soga J; Yakuwa Y
J Exp Clin Cancer Res; 1999 Mar; 18(1):13-22. PubMed ID: 10374671
[TBL] [Abstract][Full Text] [Related]
6. Endocrine tumors of the duodenum. A study of 55 cases relative to clinicopathological features and hormone content.
Heymann MF; Hamy A; Triau S; Miraillé E; Toquet C; Chomarat H; Cohen C; Maitre F; Le Bodie MF
Hepatogastroenterology; 2004; 51(59):1367-71. PubMed ID: 15362754
[TBL] [Abstract][Full Text] [Related]
7. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
Anlauf M; Schlenger R; Perren A; Bauersfeld J; Koch CA; Dralle H; Raffel A; Knoefel WT; Weihe E; Ruszniewski P; Couvelard A; Komminoth P; Heitz PU; Klöppel G
Am J Surg Pathol; 2006 May; 30(5):560-74. PubMed ID: 16699310
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases.
Chatzipantelis P; Salla C; Konstantinou P; Karoumpalis I; Sakellariou S; Doumani I
Cancer; 2008 Aug; 114(4):255-62. PubMed ID: 18618505
[TBL] [Abstract][Full Text] [Related]
9. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
10. Somatostatinoma: clinico-pathological features of three cases and literature reviewed.
Nesi G; Marcucci T; Rubio CA; Brandi ML; Tonelli F
J Gastroenterol Hepatol; 2008 Apr; 23(4):521-6. PubMed ID: 17645474
[TBL] [Abstract][Full Text] [Related]
11. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.
Hoffmann KM; Furukawa M; Jensen RT
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):675-97. PubMed ID: 16253893
[TBL] [Abstract][Full Text] [Related]
12. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
13. Endocrine tumors of the duodenum and upper jejunum. A study of 33 cases with clinico-pathological characteristics and hormone content.
Capella C; Riva C; Rindi G; Usellini L; Chiaravalli A; Solcia E
Hepatogastroenterology; 1990 Apr; 37(2):247-52. PubMed ID: 2160422
[TBL] [Abstract][Full Text] [Related]
14. Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.
Rosentraeger MJ; Garbrecht N; Anlauf M; Raffel A; Knoefel WT; Wiedenmann B; Klöppel G
Virchows Arch; 2016 Mar; 468(3):277-87. PubMed ID: 26649731
[TBL] [Abstract][Full Text] [Related]
15. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
16. Duodenal somatostatinoma associated with Von Recklinghausen's disease.
Fendrich V; Ramaswamy A; Slater EP; Bartsch DK
J Hepatobiliary Pancreat Surg; 2004; 11(6):417-21. PubMed ID: 15619018
[TBL] [Abstract][Full Text] [Related]
17. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.
Hermann G; Konukiewitz B; Schmitt A; Perren A; Klöppel G
Virchows Arch; 2011 Aug; 459(2):147-54. PubMed ID: 21739268
[TBL] [Abstract][Full Text] [Related]
18. [Clinical genetics of neuroendocrine tumors].
Karges W; Adler G
Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
[TBL] [Abstract][Full Text] [Related]
19. [Somatostatin-producing endocrine pancreatic tumor in Recklinghausen's neurofibromatosis. Case report and literature review].
Saurenmann P; Binswanger R; Maurer R; Stamm B; Hegglin J
Schweiz Med Wochenschr; 1987 Jul; 117(30):1134-9. PubMed ID: 2890200
[TBL] [Abstract][Full Text] [Related]
20. Management of gastric and duodenal neuroendocrine tumors.
Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
